p16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract

Virchows Archiv

Volumn 438, Issue 4, 2001, Pages 343-349

  Ambrosch, Petra ^a   Schlott, T ^a   Hilmes, D ^a   Ruschenburg, I ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Carcinogenesis; Head and neck squamous cell carcinoma; p16; pRb; Tumor suppressor

Indexed keywords

CYCLINE; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; DYSPLASIA; FEMALE; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL DISEASE; GENE DELETION; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UPPER GASTROINTESTINAL TRACT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; DNA, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETINOBLASTOMA PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0035071833     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000368     Document Type: Article

References (41)

1. Inactivation patterns of the p16 (INK4a) gene in oral squamous cell carcinoma cell lines
2. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control
3. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
4. Genetic progression model for head and neck cancer: Implication for field cancerization
5. p16 mutation frequency and clinical correlation in head and neck cancer
6. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma
7. INKA4A in archival human solid tumors. Correlation with retinoblastoma protein expression
8. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma
9. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
10. MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx
11. A cell cycle regulator potentially involved in genesis of many tumor types
12. INK4a expression in resected non-small cell lung tumors
13. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas
14. Frequent mutation of p16 in squamous cell carcinoma of the head and neck
15. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRB
16. p16 and p16b are potent growth suppressors of head and neck squamous carcinoma cells in vitro
17. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer
18. Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors
19. Molecular support for field cancerization in the head and neck
20. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas. Identification of two distinct regions of preferential loss
21. Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions
22. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CGKN2/MTS1 in human cancers
23. High prevalence of p16 genetic alterations in head and neck tumours
24. In vitro growth suppre ssion by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck
25. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma
26. INK4 in human cancer
27. Alterations of the p16 gene in head and neck cancer: Frequency and association with p53, PRAD-1 and HPV
28. INK4a in oral premalignant lesions
29. Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinomas using quantitative polymerase chain reaction method
30. High frequency of p16 (CDKN2/MTS-1/INK4 A) inactivation in head and neck squamous cell carcinoma
31. Tumor suppressor gene p16 (CDKN2 A) mutation status and promoter inactivation in head and neck cancer
32. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
33. Role of the INK4a locus in tumor suppression and cell mortality
34. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker
35. INK4A) somatic and germline mutations
36. DNA content and PCNA immunoreactivity in oral precancerous and cancerous lesions
37. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses
38. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma
39. Deletions of chromosome 13q, mutations in Rb-1 and Rb proteins state in human hepatocellular carcinoma
40. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx